Designing new antivirals requires the detailed molecular and structural understanding of key steps in virus replication.
Human respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and pneumonia in infants and elderly worldwide. The underlying mechanisms facilitating infection such as virus filament formation and budding is poorly understood.
Further details: Molecular insight into virus budding